Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tenax Therapeutics (TENX) Other Operating Expenses (2016 - 2022)

Tenax Therapeutics' Other Operating Expenses history spans 5 years, with the latest figure at $33.3 million for Q4 2016.

  • On a quarterly basis, Other Operating Expenses changed N/A to $33.3 million in Q4 2016 year-over-year; TTM through Sep 2017 was $33.3 million, a N/A change, with the full-year FY2021 number at -$254832.0, down 1302.8% from a year prior.
  • Other Operating Expenses hit $33.3 million in Q4 2016 for Tenax Therapeutics, up from $1.0 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for TENX hit a ceiling of $33.3 million in Q4 2016 and a floor of $27279.0 in Q2 2013.
  • Historically, Other Operating Expenses has averaged $8.6 million across 4 years, with a median of $532198.5 in 2012.
  • Biggest five-year swings in Other Operating Expenses: tumbled 90.22% in 2012 and later decreased 7.64% in 2013.
  • Tracing TENX's Other Operating Expenses over 4 years: stood at $29534.0 in 2012, then decreased by 7.64% to $27279.0 in 2013, then surged by 3693.63% to $1.0 million in 2015, then skyrocketed by 3114.44% to $33.3 million in 2016.
  • Business Quant data shows Other Operating Expenses for TENX at $33.3 million in Q4 2016, $1.0 million in Q2 2015, and $27279.0 in Q2 2013.